SEC Form 4 · accession 0001209191-19-017820
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Edward Bass
Director
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stock | Mar 5, 2019 | G | 2,631 | $0.00 | D | 51,479 | D | |
| Class A common stock | Mar 5, 2019 | S | 5,852 | $100.2939 | D | 11,703 | I | By Bass Trust FBO James E. Bass |
| Class A common stock | holding | — | — | — | 41,902 | I | By Bass Family Trust A |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1A portion of the shares sold and reported herein is matchable under Section 16(b) of the Securities and Exchange Act of 1934 ("Section 16(b)"). The Reporting Person has voluntarily disgorged to the Issuer the Section 16(b) profit that resulted from the transaction reported herein.